SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVictrex Regulatory News (VCT)

Share Price Information for Victrex (VCT)

Share Price is delayed by 15 minutes
Get Live Data
620.00    9.00 (1.47%)
Bid:
621.00
Ask:
623.00
Spread: 2.00 (0.322%)
Market Cap: £540.17m
VCT Live PriceLast checked at - London Stock Exchange

Intraday Victrex Share Chart

Trading Statement

9 Oct 2014 07:00

RNS Number : 8130T
Victrex PLC
09 October 2014
 



 

 

 

 

9 October 2014

 

Victrex plc - Pre-close trading statement

 

"A strong finish to 2014 - growth momentum continues"

 

Victrex plc, an innovative world leader in high performance polymer solutions, today releases its pre-close trading statement for the financial year ended 30 September 2014, ahead of its preliminary results on Tuesday 9 December 2014.

 

Victrex delivered a strong finish to 2014, with the Group continuing its volume growth momentum from the first half year across our strategic markets of Automotive, Aerospace, Energy, Electronics and Medical. Full year Group sales volume of 3,551 tonnes increased by 22% (2013: 2,920 tonnes), with second half year sales volume of 1,967 tonnes increasing by 29% on last year (H2 2013: 1,528 tonnes). Although sales volumes were particularly strong, our profit expectations remain largely unchanged.

 

The strong volume performance in our Victrex Polymer Solutions (VPS) business reflects core growth and higher than expected volumes in the second half year from Consumer Electronics. Stripping out sales volumes across the entire Electronics segment, second half year sales volume increased by 6% on the prior year. Our higher margin Speciality Products business, including Aptiv film, again performed well during the year. With continued growth in Aptiv, we will bring an additional production line on stream during the first half of our new financial year.

 

In our higher margin Invibio medical business, full year revenue increased by 5% to £53.4m (2013: £50.8m), reflecting steady improvement in the Spine market. The focus for 2015 remains the roll-out of new products into the Spine market, with regulatory applications lodged in the US and Europe for the innovative PEEK-OPTIMA® HA-Enhanced product, which enhances bone-on-growth. Pending regulatory approval, adoption and roll-out will commence during the first half.

 

As we start our new financial year, our growth momentum remains positive. Although currency headwinds remain considerable in 2015, our forthcoming new PEEK and Aptiv film capacity, technical excellence and marketing know-how keep us well placed to continue driving growth and creating value, in line with our long term strategy.

 

Enquiries:

 

Victrex plc:

Andrew Hanson, Head of Investor Relations & Communications +44 (0) 1253 898121

Louisa Burdett, Group Finance Director +44 (0) 1253 897700

 

Pendomer Communications:

Charles Armitstead / Rebecca Hall +44 (0) 203 603 5220

 

About Victrex:

Victrex is an innovative world leader in high performance polymer solutions focused on the strategic markets of Aerospace, Automotive, Electronics, Energy and Medical. Every day, millions of people rely on products or applications which contain our polymers, from smartphones, aeroplanes and cars to oil & gas operations and medical devices. With over 35 years' experience, we are investing in technical excellence to deliver new and leading edge solutions to our customers and our markets, and to drive value for our shareholders. Visit www.victrexplc.com

 

Investor and analyst call:

A call for investors and analysts will be held today, Thursday 9 October 08.30 UK time. For dial in details contact Rebecca Hall at Pendomer on +44 (0) 203 603 5220 or Rebecca.Hall@pendomer.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUGGBAUUPCGCR
Date   Source Headline
17th Jun 202111:29 amRNSDirector/PDMR Shareholding
16th Jun 20212:13 pmRNSAdditional Listing
2nd Jun 202111:10 amRNSDirector/PDMR Shareholding
1st Jun 20219:35 amRNSBlock listing Interim Review
28th May 20211:09 pmRNSTotal Voting Rights
18th May 20214:50 pmRNSDirector Declaration
18th May 202110:32 amRNSDirector/PDMR Shareholding
17th May 202110:56 amRNSDirector/PDMR Shareholding
13th May 202110:08 amRNSAdditional Listing
10th May 20217:00 amRNSVictrex plc Interim Results
30th Apr 20212:41 pmRNSTotal Voting Rights
19th Apr 20212:37 pmRNSDirector/PDMR Shareholding
16th Apr 202110:36 amRNSDirector Declaration
9th Apr 202111:00 amRNSAdditional Listing
31st Mar 20211:52 pmRNSTotal Voting Rights
17th Mar 20211:41 pmRNSDirector/PDMR Shareholding
1st Mar 202111:37 amRNSDirector/PDMR Shareholding
26th Feb 20211:47 pmRNSTotal Voting Rights
17th Feb 202110:32 amRNSDirector/PDMR Shareholding
12th Feb 20211:53 pmRNSResult of AGM
12th Feb 20217:00 amRNSAGM and Q1 Interim Management Statement
10th Feb 20212:37 pmRNSDirector/PDMR Shareholding
29th Jan 20212:33 pmRNSTotal Voting Rights
19th Jan 20213:50 pmRNSDirector/PDMR Shareholding
7th Jan 20212:06 pmRNSAnnual Report and Accounts
6th Jan 20212:34 pmRNSDirector/PDMR Shareholding
31st Dec 20209:00 amRNSTotal Voting Rights
17th Dec 20203:09 pmRNSDirector/PDMR Shareholding
15th Dec 202012:57 pmRNSDirector/PDMR Shareholding
11th Dec 20202:47 pmRNSDirector/PDMR Shareholding
9th Dec 20207:00 amRNSVictrex plc – Preliminary Results 2020
1st Dec 202010:59 amRNSBlock listing Interim Review
30th Nov 202011:24 amRNSTotal Voting Rights
17th Nov 20209:49 amRNSDirector/PDMR Shareholding
30th Oct 202011:40 amRNSTotal Voting Rights
19th Oct 202011:34 amRNSDirector/PDMR Shareholding
14th Oct 202012:17 pmRNSHolding(s) in Company
6th Oct 20207:00 amRNSVictrex plc Full Year Trading Statement
30th Sep 20209:30 amRNSTotal Voting Rights
29th Sep 20204:09 pmRNSHolding(s) in Company
17th Sep 202011:00 amRNSDirector/PDMR Shareholding
28th Aug 20209:56 amRNSTotal Voting Rights
19th Aug 202011:01 amRNSDirector/PDMR Shareholding
31st Jul 202011:53 amRNSTotal Voting Rights
20th Jul 202010:45 amRNSDirector/PDMR Shareholding
17th Jul 20204:43 pmRNSDirector/PDMR Shareholding
8th Jul 20207:00 amRNSVictrex Q3 Interim Management Statement
30th Jun 202011:30 amRNSTotal Voting Rights
17th Jun 202011:44 amRNSDirector/PDMR Shareholding
15th Jun 20204:24 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.